How many times have you been told to “finish the entire box of antibiotics,” even when you already felt you were back on your feet? This advice, pounded into us for decades by doctors and pharmacists alike, seems like a truth carved in stone. Yet, a recent clinical trial is seriously challenging this certainty and raises a troubling question: are we sometimes swallowing pills for nothing?
Finishing the box: the advice that no one has really verified
Completing one’s treatment scrupulously is one of the most ingrained health reflexes in our culture. The underlying idea seems to be common sense: if you stop too early, the toughest bacteria would survive and become resistant. A tempting line of reasoning, but when you look closer, it has never rested on solid evidence.
The reality is that treatment durations have long been set somewhat by rule of thumb. Depending on the country and the habits, they ranged between seven and fourteen days, without real scientific justification. These figures were more the product of inherited tradition than of rigorous demonstration. In other words, the famous “finish the box” sometimes looked like a medical grandmother’s recipe, handed down without truly questioning its foundation.
What the clinical trial actually measured, and why it’s serious
This is where large-scale research comes into play. A study conducted in 67 hospitals compared, among patients hospitalized for community-acquired pneumonia, a short course of three to four days with a standard five days or more. The verdict is clear: for patients clinically stable by day three, the 30-day outcomes were quite comparable between the two approaches.
However, be careful not to discard your pills at the first sign of improvement. The inclusion criteria were particularly strict: no fever, no need for extra oxygen, and stable vital signs. As a result, only one in ten hospitalized patients met all these conditions. The message is therefore not “shorten at all costs,” but rather “when the situation allows, less can suffice.” A French trial, involving patients with a median age of 73, had already pointed in the same direction by comparing three days of treatment to eight.
“Non-inferiority”: the tricky word that changes everything for your health
The keyword of all these studies is non-inferiority. To translate this jargon: it’s not about proving that a short treatment is better, but that it performs just as well as the longer treatment, without compromising the patient’s chances. Imagine two routes to the same destination: one shorter, the other longer, but you reach the destination in both cases. Why endure the more arduous journey?
And pneumonia isn’t an isolated case. For some skin infections, six days of treatment proved as effective as ten. For bloodstream infections, seven days stood up to fourteen. Each time, the same lesson: the historical duration was often oversized. Fewer antibiotics also mean fewer side effects, better adherence, and, above all, a valuable brake on the dreaded bacterial resistance.
What these results mean for you, from your next prescription
Should we conclude that we should now improvise the end of our treatment? Not at all. These findings apply to very specific situations, evaluated by professionals using strict criteria. The right reflex remains to follow the prescription and to discuss with your doctor rather than deciding alone at home that a few tablets will suffice.
The real novelty lies elsewhere: official recommendations are now evolving. In France, these advances have already led to revising several guidelines and publishing updated summary sheets. Concretely, your doctor could prescribe, tomorrow, a shorter duration than what you were used to. And it won’t be a lapse: it will be science finally catching up with our old habits.
The reflex to finish the box is therefore neither entirely right nor completely to be dismissed. It mainly reflects a time when the ideal duration remained a poorly clarified mystery. Today, the trend is clear: shorter, when possible, is often better. So, next time you’re handed a prescription, will you dare to ask the troubling question: “Doctor, is this really to the end?”
Source : Doumat G., Ratz D., Horowitz J.K. et al. — “Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia: A Multicenter Target Trial Emulation” — Annals of Internal Medicine, published online on April 14, 2026
